glutathione thyrodi cancer Selective anti-tumor activity of glutathione-responsive abasic site trapping agent in anaplastic thyroid carcinoma | BMC Thyroid cancer paper lands national

What it may do is support the health of follicles that are still active at the hairline, slow the pace of miniaturization through a non-hormonal mechanism, and complement treatments with stronger evidence

Discover how this next-gen treatment redefines body contouring efficiency

Hepatic arterial infusion A systematic review of 16 studies including 331 patients, of whom a large proportion had bilobar disease (75%), multifocal tumours (66%) and a high incidence of macrovascular invasion (~40%), found that HAI achieved a pooled response rate of 41.3%, with a median PFS of 10 months and a median overall survival of 21.3 months 275

Athletic Performance: Reduces exercise-induced oxidative stress and improve recovery